The prognosis of glioblastoma: a large, multifactorial study

References

• Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011–2015. Neuro Oncol 2018; 20:iv1–v86.
   PubMed Web of Science ®Google Scholar
• Ostrom QT, Gittleman H, Xu J, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2009–2013. Neuro Oncol 2016; 18:v1–75.
   PubMed Web of Science ®Google Scholar
• Perry JR, Laperriere N, O Callaghan CJ, et al. Short-course radiation plus temozolomide in elderly patients with glioblastoma. N Engl J Med 2017; 376:1027–37.
   PubMed Web of Science ®Google Scholar
• Thakkar JP, Dolecek TA, Horbinski C, et al. Epidemiologic and molecular prognostic review of glioblastoma. Cancer Epidemiol Biomarkers Prev 2014; 23:1985–96.
   PubMed Web of Science ®Google Scholar
• Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352:987–96.
   PubMed Web of Science ®Google Scholar
• Aldape K, Zadeh G, Mansouri S, Reifenberger G, von Deimling A. Glioblastoma: pathology, molecular mechanisms and markers. Acta Neuropathol 2015; 129:829–48.
   PubMed Web of Science ®Google Scholar
• Weller M, Wick W, Aldape K, et al. Glioma. Nat Rev Dis Primers 2015;1:15017.
   PubMed Web of Science ®Google Scholar
• Iorgulescu B. OS04.3 Extent of resection and overall survival in risk adjusted and exact matched analyses of 22,928 glioblastoma (all molecular subtypes) patients. Neuro-Oncology 2017;19:iii7.
   Web of Science ®Google Scholar
• Li YM, Suki D, Hess K, Sawaya R. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: can we do better than gross-total resection? J Neurosurg 2016;124:977–88.
   PubMed Web of Science ®Google Scholar
• Eriksson M, Kahari J, Vestman A, et al. Improved treatment of glioblastoma - changes in survival over two decades at a single regional Centre. Acta Oncol 2019;58:334–41.
   PubMed Web of Science ®Google Scholar
• Gusev Y, Bhuvaneshwar K, Song L, Zenklusen J, Fine H, Madhavan S. The REMBRANDT study, a large collection of genomic data from brain cancer patients. Sci Data 2018;5:180158
   PubMed Web of Science ®Google Scholar
• Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007;114:97–109.
   PubMed Web of Science ®Google Scholar
• Ogura R, Tsukamoto Y, Natsumeda M, et al. Immunohistochemical profiles of IDH1, MGMT and P53: practical significance for prognostication of patients with diffuse gliomas. Neuropathology 2015;35:324–35.
   PubMed Web of Science ®Google Scholar
• Reuss DE, Kratz A, Sahm F, et al. Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities. Acta Neuropathol 2015;130:407–17.
   PubMed Web of Science ®Google Scholar
• Kim BS, Kong DS, Seol HJ, Nam DH, Lee JI. MGMT promoter methylation status as a prognostic factor for the outcome of gamma knife radiosurgery for recurrent glioblastoma. J Neurooncol 2017;133:615–22.
   PubMed Web of Science ®Google Scholar
• Gravendeel LA, Kouwenhoven MC, Gevaert O, et al. Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology. Cancer Res 2009; 69:9065–72.
   PubMed Web of Science ®Google Scholar
• Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008;455:1061–8.
   PubMed Web of Science ®Google Scholar
• Wen PY, Macdonald DR, Reardon DA, et al. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 2010;28:1963–72.
   PubMed Web of Science ®Google Scholar
• Khan I, Waqas M, Shamim MS. Role of Intra-operative MRI (iMRI) in improving extent of resection and survival in patients with glioblastoma multiforme. J Pak Med Assoc 2017;67:1121–3.
   PubMed Web of Science ®Google Scholar
• Marongiu A, D'Andrea G, Raco A. 1.5-T field intraoperative magnetic resonance imaging improves extent of resection and survival in glioblastoma removal. World Neurosurg 2017;98:578–86.
   PubMed Web of Science ®Google Scholar
• Coburger J, Segovia Von Riehm J, Ganslandt O, Wirtz CR, Renovanz M. Is there an indication for intraoperative MRI in subtotal resection of glioblastoma? A multicenter retrospective comparative analysis. World Neurosurg 2018;110:e389–97.
   PubMed Web of Science ®Google Scholar